[artículo] 
inJournal of Clinical Psychopharmacology > Año 2001 - Vol. 21 - No. 1 (Febrero) . - pp. 14-20

Título :	Olanzapine plasma concentrations and clinical response: acute phase results of the north american olanzapine trial
Tipo de documento:	texto impreso
Autores:	Paul J. Perry, Autor ; Brian C. Lund, Autor ; Todd Sanger, Autor
Fecha de publicación:	2023
Artículo en la página:	pp. 14-20
Idioma :	Inglés (eng) Idioma original : Inglés (eng)
Palabras clave:	Antipsicóticos, Benzodiazepinas, Pirenzepina, Esquizofrenia.
Resumen:	Olanzapine is an atypical antipsychotic that is effective in the treatment of schizophrenia. Olanzapine plasma concentrations ≥ 9.3 ng/mL (24 hours postdose) have been identified as a predictor of clinical response in acutely ill patients with schizophrenia. The authors report a receiver operating characteristic (ROC) curve analysis of 12-hour olanzapine concentrations and treatment response from the North American Double-Blind Olanzapine Trial.
Link:	./index.php?lvl=notice_display&id=31132

[artículo] Olanzapine plasma concentrations and clinical response: acute phase results of the north american olanzapine trial [texto impreso] / Paul J. Perry, Autor ; Brian C. Lund, Autor ; Todd Sanger, Autor . - 2023 . - pp. 14-20.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in Journal of Clinical Psychopharmacology > Año 2001 - Vol. 21 - No. 1 (Febrero) . - pp. 14-20

Palabras clave:	Antipsicóticos, Benzodiazepinas, Pirenzepina, Esquizofrenia.
Resumen:	Olanzapine is an atypical antipsychotic that is effective in the treatment of schizophrenia. Olanzapine plasma concentrations ≥ 9.3 ng/mL (24 hours postdose) have been identified as a predictor of clinical response in acutely ill patients with schizophrenia. The authors report a receiver operating characteristic (ROC) curve analysis of 12-hour olanzapine concentrations and treatment response from the North American Double-Blind Olanzapine Trial.
Link:	./index.php?lvl=notice_display&id=31132